Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

"Shifting sands in cystic fibrosis": impacts of CFTR modulators on reproductive health in people with cystic fibrosis and challenges related to in utero exposure.

Expert opinion on pharmacotherapy - 1 Dec 2024

Felton Imogen, Downes Amy, Bokobza Idan, Weitnauer Ladina, Davies Jane C

Abstract excerpt

INTRODUCTION: Mutation-specific disease modifying drugs such as the triple combination Elexacaftor/Tezacaftor/Ivacaftor (ETI), are associated with significant improvements in physical health. Reproductive health and a pursuit of parenthood are of increased relevance; a dramatic increase in childbirth rates for females with CF has already been observed. AREAS COVERED: Fertility in males and females with CF, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Indoles

Share to Pregnancy Complications

Share to Prenatal Exposure Delayed Effects

Share to Pyrazoles

Share to Quinolones

Source

Identifiers

PMID: 39543810
DOI: 10.1080/14656566.2024.2426677

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

"Shifting sands in cystic fibrosis": impacts of CFTR modulators on reproductive health in people with cystic fibrosis and challenges related to in utero exposure.PMID 39543810Read ↗

CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic FibrosisSemantic proximity Read ↗

Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis.Semantic proximity Read ↗

Use of CFTR modulators in special populations, part 1: Pregnancy and lactation.Semantic proximity Read ↗

Extent of foetal exposure to maternal elexacaftor/tezacaftor/ivacaftor during pregnancySemantic proximity Read ↗

Pregnancy in cystic fibrosis: Review of the literature and expert recommendationsSemantic proximity Read ↗

Pregnancy in Cystic Fibrosis: Review of the Literature and Expert RecommendationsSemantic proximity Read ↗

Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy.Semantic proximity Read ↗

Cystic fibrosis: new challenges and perspectives beyond elexacaftor/tezacaftor/ivacaftor.Semantic proximity Read ↗

The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis.Semantic proximity Read ↗

The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis.Semantic proximity Read ↗

CFTR modulator therapy via carrier mother to treat meconium ileus in a F508del homozygous fetus: Insights from an unsuccessful caseSemantic proximity Read ↗

Use of elexacaftor/tezacaftor/ivacaftor combination in pregnancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.